Recapitulating endochondral ossification: A promising route to in vivo bone regeneration

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 8, 2015, Pages 889-902

  Thompson, Emmet M ^a,b,c   Matsiko, Amos ^a,b,c   Farrell, Eric ^d   Kelly, Daniel J ^b,c   O'Brien, Fergal J ^a,b,c  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c Advanced Materials and Bioengineering Research (AMBER) Centre   (Ireland)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bone; Developmental engineering; Endochondral ossification; Hypertrophy; Intramembranous ossification; Mesenchymal stem cells

Indexed keywords

BIOMIMETICS; BONE; CELL ENGINEERING; DEFECTS; DEPOSITION; SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE REGENERATION;

BONE FORMATION; BONE REGENERATION; CRITICAL SIZED DEFECTS; DEVELOPMENTAL ENGINEERINGS; ENDOCHONDRAL OSSIFICATION; IN-VITRO; IN-VIVO; INTRAMEMBRANOI OSSIFICATION; MESENCHYMAL STEM CELL; TISSUES ENGINEERINGS;

CELL CULTURE;

AGAROSE; ALGINIC ACID; BIOMATERIAL; CHITOSAN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; FIBRIN; GELATIN; HYALURONIC ACID; MACROGOL; MATRIX METALLOPROTEINASE; NANOFIBER; POLY(ETHYLENE OXIDE)DIACRYLATE; POLYACRYLAMIDE; POLYCAPROLACTONE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; SILK FIBROIN; SULPHONATE COATED POLYACRYLAMIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

BONE REGENERATION; BONE REMODELING; CARTILAGE CELL; CELL MATURATION; DISEASE MODEL; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENCHONDRAL OSSIFICATION; ENZYME ACTIVITY; FRACTURE HEALING; HUMAN; HUMAN ARTICULAR CHONDROCYTE; HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INTRAMEMBRANOUS OSSIFICATION; MESENCHYMAL STEM CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; REVIEW; TISSUE CULTURE; TISSUE ENGINEERING; TISSUE SCAFFOLD; ANIMAL; BONE; BONE DEVELOPMENT; CARTILAGE; CHEMISTRY; CYTOLOGY; EXTRACELLULAR MATRIX; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE REGENERATION; CARTILAGE; CHONDROCYTES; EXTRACELLULAR MATRIX; FRACTURE HEALING; HUMANS; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOGENESIS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84938748896     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1918     Document Type: Review

References (160)

1. Arenas-Herrera JE, Ko IK, Atala A, et al. 2013; Decellularization for whole organ bioengineering. Biomed Mater 8: 014106.
2. Badylak SF, Gilbert TW. 2008; Immune response to biologic scaffold materials. Semin Immunol 20: 109-116.
3. Baker J, Liu JP, Robertson EJ, et al. 1993; Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82.
4. Barron MJ, Goldman J, Tsai CJ, et al. 2012; Perfusion flow enhances osteogenic gene expression and the infiltration of osteoblasts and endothelial cells into three-dimensional calcium phosphate scaffolds. Int J Biomater 2012: 915620.
5. Bastow ER, Last K, Golub S, et al. 2012; Evidence for lysosomal exocytosis and release of aggrecan-degrading hydrolases from hypertrophic chondrocytes, in vitro and in vivo. Biol Open 1: 318-328.
6. Beyth S, Borovsky Z, Mevorach D, et al. 2005; Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105: 2214-2219.
7. Bian L, Hou C, Tous E, et al. 2013; The influence of hyaluronic acid hydrogel crosslinking density and macromolecular diffusivity on human MSC chondrogenesis and hypertrophy. Biomaterials 34: 413-421.
8. Bianco P, Cao X, Frenette PS, et al. 2013; The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 19: 35-42.
9. Boccaccini AR, Kneser U, Arkudas A. 2012; Scaffolds for vascularized bone regeneration: advances and challenges. Expert Rev Med Devices 9: 457-460.
10. Bostrom MP, Seigerman DA. 2005; The clinical use of allografts, demineralized bone matrices, synthetic bone graft substitutes and osteoinductive growth factors: a survey study. Hosp Spec Surg J 1: 9-18.
11. Boyan BD, Schwartz Z, Swain LD. 1992; In vitro studies on the regulation of endochondral ossification by vitamin D. Crit Rev Oral Biol Med 3: 15-30.
12. Boyce MK, Trumble TN, Carlson CS, et al. 2013; Non-terminal animal model of post-traumatic osteoarthritis induced by acute joint injury. Osteoarthr Cartilage 21: 746-755.
13. Brown BN, Londono R, Tottey S, et al. 2012; Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater 8: 978-987.
14. Buckley CT, Vinardell T, Thorpe SD, et al. 2010; Functional properties of cartilaginous tissues engineered from infrapatellar fat pad-derived mesenchymal stem cells. J Biomech 43: 920-926.
15. Burke JF, Yannas IV, Quinby WC Jr, et al. 1981; Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 194: 413-428.
16. Buxton AN, Zhu J, Marchant R, et al. 2007; Design and characterization of poly(ethylene glycol) photopolymerizable semi-interpenetrating networks for chondrogenesis of human mesenchymal stem cells. Tissue Eng 13: 2549-2560.
17. Cals FL, Hellingman CA, Koevoet W, et al. 2012; Effects of transforming growth factor-β subtypes on in vitro cartilage production and mineralization of human bone marrow stromal-derived mesenchymal stem cells. J Tissue Eng Regen Med 6: 68-76.
18. Caplan AI. 2007; Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213: 341-347.
19. Caplan AI, Correa D. 2011; The MSC: an injury drugstore. Cell Stem Cell 9: 11-15.
20. Chang CF, Lee MW, Kuo PY, et al. 2007; Three-dimensional collagen fiber remodeling by mesenchymal stem cells requires the integrin-matrix interaction. J Biomed Mater Res A 80: 466-474.
21. Chen X, Zhang F, He X, et al. 2013; Chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells in type I collagen-hydrogel for cartilage engineering. Injury 44: 540-549.
22. Cheung C. 2005; The future of bone healing. Clin Podiatr Med Surg 22: 631-641, viii.
23. Cleary MA, van Osch GJ, Brama PA, et al. 2013; FGF, TGFβ and Wnt crosstalk: embryonic to in vitro cartilage development from mesenchymal stem cells. J Tissue Eng Regen Med. DOI: 10.1002/term.1744 [Epub ahead of print].
24. Dai J, Rabie AB. 2007; VEGF: an essential mediator of both angiogenesis and endochondral ossification. J Dent Res 86: 937-950.
25. De Bari C, Dell'Accio F, Tylzanowski P, et al. 2001; Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44: 1928-1942.
26. De Miguel MP, Fuentes-Julian S, Blazquez-Martinez A, et al. 2012; Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med 12: 574-591.
27. Dickhut A, Gottwald E, Steck E, et al. 2008; Chondrogenesis of mesenchymal stem cells in gel-like biomaterials in vitro and in vivo. Front Biosci 13: 4517-4528.
28. Dragoo JL, Samimi B, Zhu M, et al. 2003; Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br 85B: 740-747.
29. Dreier R, Gunther BK, Mainz T, et al. 2008; Terminal differentiation of chick embryo chondrocytes requires shedding of a cell surface protein that binds 1, 25-dihydroxyvitamin D3. J Biol Chem 283: 1104-1112.
30. Duffy GP, McFadden TM, Byrne EM, et al. 2011; Towards in vitro vascularisation of collagen-GAG scaffolds. Eur Cell Mater 21: 15-30.
31. Engler AJ, Sen S, Sweeney HL, et al. 2006; Matrix elasticity directs stem cell lineage specification. Cell 126: 677-689.
32. Farrell E, Both SK, Odorfer KI, et al. 2011; In vivo generation of bone via endochondral ossification by in vitro chondrogenic priming of adult human and rat mesenchymal stem cells. BMC Musculoskelet Disord 12: 31.
33. Farrell E, O'Brien FJ, Doyle P, et al. 2006; A collagen-glycosaminoglycan scaffold supports adult rat mesenchymal stem cell differentiation along osteogenic and chondrogenic routes. Tissue Eng 12: 459-468.
34. Farrell E, van der Jagt OP, Koevoet W, et al. 2009; Chondrogenic priming of human bone marrow stromal cells: a better route to bone repair? Tissue Eng C Meth 15: 285-295.
35. Filion TM, Li X, Mason-Savas A, et al. 2011; Elastomeric osteoconductive synthetic scaffolds with acquired osteoinductivity expedite the repair of critical femoral defects in rats. Tissue Eng A 17: 503-511.
36. Fischer CR, Cassilly R, Cantor W, et al. 2013; A systematic review of comparative studies on bone graft alternatives for common spine fusion procedures. Eur Spine J 22: 1423-1435.
37. Fuchs S, Dohle E, Kirkpatrick CJ. 2012; Sonic Hedgehog-mediated synergistic effects guiding angiogenesis and osteogenesis. Vitam Horm 88: 491-506.
38. Gerstenfeld LC, Cullinane DM, Barnes GL, et al. 2003; Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88: 873-884.
39. Gerstenfeld LC, Shapiro FD. 1996; Expression of bone-specific genes by hypertrophic chondrocytes: implication of the complex functions of the hypertrophic chondrocyte during endochondral bone development. J Cell Biochem 62: 1-9.
40. Giavaresi G, Bondioli E, Melandri D, et al. 2013; Response of human chondrocytes and mesenchymal stromal cells to a decellularized human dermis. BMC Musculoskelet Disord 14: 12.
41. Glatt V, Miller M, Ivkovic A, et al. 2012; Improved healing of large segmental defects in the rat femur by reverse dynamization in the presence of bone morphogenetic protein-2. J Bone Joint Surg Am 94: 2063-2073.
42. Goldring MB, Tsuchimochi K, Ijiri K. 2006; The control of chondrogenesis. J Cell Biochem 97: 33-44.
43. Grabowski G, Cornett CA. 2013; Bone graft and bone graft substitutes in spine surgery: current concepts and controversies. J Am Acad Orthop Surg 21: 51-60.
44. Grimsrud CD, Romano PR, D'Souza M, et al. 1999; BMP-6 is an autocrine stimulator of chondrocyte differentiation. J Bone Miner Res 14: 475-482.
45. Grimsrud CD, Romano PR, D'Souza M, et al. 2001; BMP signaling stimulates chondrocyte maturation and the expression of Indian hedgehog. J Orthop Res 19: 18-25.
46. Hellingman CA, Koevoet W, Kops N, et al. 2010; Fibroblast growth factor receptors in in vitro and in vivo chondrogenesis: relating tissue engineering using adult mesenchymal stem cells to embryonic development. Tissue Eng A 16: 545-556.
47. Ho ST, Cool SM, Hui JH, et al. 2010; The influence of fibrin based hydrogels on the chondrogenic differentiation of human bone marrow stromal cells. Biomaterials 31: 38-47.
48. Huang AH, Farrell MJ, Mauck RL. 2010; Mechanics and mechanobiology of mesenchymal stem cell-based engineered cartilage. J Biomech 43: 128-136.
49. Huang GS, Dai LG, Yen BL, et al. 2011; Spheroid formation of mesenchymal stem cells on chitosan and chitosan-hyaluronan membranes. Biomaterials 32: 6929-6945.
50. Huang JI, Durbhakula MM, Angele P, et al. 2006; Lunate arthroplasty with autologous mesenchymal stem cells in a rabbit model. J Bone Joint Surg Am 88: 744-752.
51. Hunziker EB, Kapfinger E, Saager C. 1999; Hypertrophy of growth plate chondrocytes in vivo is accompanied by modulations in the activity state and surface area of their cytoplasmic organelles. Histochem Cell Biol 112: 115-123.
52. Im G II, Shin YW, Lee KB. 2005; Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthr Cartilage 13: 845-853.
53. Ito K, Perren S. 2007; Biology and biomechanics in bone healing. In AO Principles of Fracture Management, Ruedi T, Buckley R, Moran C (eds) [books and DVD]. Thieme: New York; 9-31.
54. Janjanin S, Li WJ, Morgan MT, et al. 2008; Mold-shaped, nanofiber scaffold-based cartilage engineering using human mesenchymal stem cells and bioreactor. J Surg Res 149: 47-56.
55. Jeong CG, Zhang H, Hollister SJ. 2012; Three-dimensional polycaprolactone scaffold-conjugated bone morphogenetic protein-2 promotes cartilage regeneration from primary chondrocytes in vitro and in vivo without accelerated endochondral ossification. J Biomed Mater Res A 100: 2088-2096.
56. Johnson EO, Troupis T, Soucacos PN. 2011; Tissue-engineered vascularized bone grafts: basic science and clinical relevance to trauma and reconstructive microsurgery. Microsurgery 31: 176-182.
57. Johnstone B, Hering TM, Caplan AI, et al. 1998; In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238: 265-272.
58. Jukes JM, Both SK, Leusink A, et al. 2008; Endochondral bone tissue engineering using embryonic stem cells. Proc Natl Acad Sci U S A 105: 6840-6845.
59. Jung Y, Bauer G, Nolta JA. 2012; Concise review: induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 30: 42-47.
60. Kanczler JM, Ginty PJ, White L, et al. 2010; The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 31: 1242-1250.
61. Kelly DJ, Jacobs CR. 2010; The role of mechanical signals in regulating chondrogenesis and osteogenesis of mesenchymal stem cells. Birth Defects Res C Embryo Today 90: 75-85.
62. Kelly DJ, Prendergast PJ. 2005; Mechanoregulation of stem cell differentiation and tissue regeneration in osteochondral defects. J Biomech 38: 1413-1422.
63. Keogh MB, Partap S, Daly JS, et al. 2011; Three hours of perfusion culture prior to 28days of static culture enhances osteogenesis by human cells in a collagen GAG scaffold. Biotechnol Bioeng 108: 1203-1210.
64. Khan SN, Cammisa FP Jr, Sandhu HS, et al. 2005; The biology of bone grafting. J Am Acad Orthop Surg 13: 77-86.
65. Kitaori T, Ito H, Schwarz EM, et al. 2009; Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 60: 813-823.
66. Ko HC, Milthorpe BK, McFarland CD. 2007; Engineering thick tissues - the vascularisation problem. Eur Cell Mater 14: 1-18; discussion, 18-19.
67. Kode JA, Mukherjee S, Joglekar MV, et al. 2009; Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 11: 377-391.
68. Koga T, Niikura T, Lee SY, et al. 2013; In vitro hypertrophy and calcification of human fracture haematoma-derived cells in chondrogenic differentiation. Int Orthop 37: 961-967.
69. Kosuge D, Khan WS, Haddad B, et al. 2013; Biomaterials and scaffolds in bone and musculoskeletal engineering. Curr Stem Cell Res Ther 8: 185-191.
70. Koyama E, Golden EB, Kirsch T, et al. 1999; Retinoid signaling is required for chondrocyte maturation and endochondral bone formation during limb skeletogenesis. Dev Biol 208: 375-391.
71. + cells in a patient with tibial nonunion: a case report. Cell Transpl 20: 1491-1496.
72. Kwon HJ. 2013; Chondrogenesis on sulfonate-coated hydrogels is regulated by their mechanical properties. J Mech Behav Biomed Mater 17: 337-346.
73. Law S, Chaudhuri S. 2013; Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges. Am J Stem Cells 2: 22-38.
74. Lee HJ, Yu C, Chansakul T, et al. 2008; Enhanced chondrogenesis of mesenchymal stem cells in collagen mimetic peptide-mediated microenvironment. Tissue Eng A 14: 1843-1851.
75. Lehmann W, Edgar CM, Wang K, et al. 2005; Tumor necrosis factor-α (TNFα) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone 36: 300-310.
76. Lenas P, Moos M, Luyten FP. 2009; Developmental engineering: a new paradigm for the design and manufacturing of cell-based products. Part I: from three-dimensional cell growth to biomimetics of in vivo development. Tissue Eng B Rev 15: 381-394.
77. Lin Z, Fitzgerald JB, Xu J, et al. 2008; Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J Orthop Res 26: 1230-1237.
78. Liu K, Zhou GD, Liu W, et al. 2008; The dependence of in vivo stable ectopic chondrogenesis by human mesenchymal stem cells on chondrogenic differentiation in vitro. Biomaterials 29: 2183-2192.
79. Liu Y, Teoh SH, Chong MS, et al. 2012; Vasculogenic and osteogenesis-enhancing potential of human umbilical cord blood endothelial colony-forming cells. Stem Cells 30: 1911-1924.
80. Lyons FG, Al-Munajjed AA, Kieran SM, et al. 2010; The healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructs. Biomaterials 31: 9232-9243.
81. Macchiarini P, Jungebluth P, Go T, et al. 2008; Clinical transplantation of a tissue-engineered airway. Lancet 372: 2023-2030.
82. Mackie EJ, Ahmed YA, Tatarczuch L, et al. 2008; Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 40: 46-62.
83. Mackie EJ, Tatarczuch L, Mirams M. 2011; The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J Endocrinol 211: 109-121.
84. Maes C, Stockmans I, Moermans K, et al. 2004; Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest 113: 188-199.
85. Mahmoudifar N, Doran PM. 2012; Chondrogenesis and cartilage tissue engineering: the longer road to technology development. Trends Biotechnol 30: 166-176.
86. Marino JT, Ziran BH. 2010; Use of solid and cancellous autologous bone graft for fractures and nonunions. Orthop Clin North Am 41: 15-26, table of contents.
87. Marsell R, Einhorn TA. 2011; The biology of fracture healing. Injury 42: 551-555.
88. Matsiko A, Levingstone TJ, O'Brien FJ, et al. 2012; Addition of hyaluronic acid improves cellular infiltration and promotes early-stage chondrogenesis in a collagen-based scaffold for cartilage tissue engineering, J Mech Behav Biomed Mater 11: 41-52.
89. Matsumoto T, Kawamoto A, Kuroda R, et al. 2006; Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol 169: 1440-1457.
90. Mauck RL, Yuan X, Tuan RS. 2006; Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. Osteoarthr Cartilage 14: 179-189.
91. McFadden TM, Duffy GP, Allen AB, et al. 2013; The delayed addition of human mesenchymal stem cells to preformed endothelial cell networks results in functional vascularization of a collagen-glycosaminoglycan scaffold in vivo. Acta Biomater 9: 9303-9316.
92. Meszaros E, Malemud CJ. 2012; Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity. Ther Adv Chronic Dis 3: 219-229.
93. Miljkovic ND, Cooper GM, Marra KG. 2008; Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthr Cartilage 16: 1121-1130.
94. Mueller MB, Fischer M, Zellner J, et al. 2010; Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGFβ isoforms and chondrogenic conditioning. Cells Tissues Organs 192: 158-166.
95. Mueller MB, Tuan RS. 2008; Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum 58: 1377-1388.
96. Mumme M, Scotti C, Papadimitropoulos A, et al. 2012; Interleukin-1β modulates endochondral ossification by human adult bone marrow stromal cells. Eur Cell Mater 24: 224-236.
97. Murphy CM, Matsiko A, Haugh MG, et al. 2012; Mesenchymal stem cell fate is regulated by the composition and mechanical properties of collagen-glycosaminoglycan scaffolds. J Mech Behav Biomed Mater 11: 53-62.
98. Nakagawa M, Kaneda T, Arakawa T, et al. 2000; Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 473: 161-164.
99. Narcisi R, Quarto R, Ulivi V, et al. 2012; TGFβ1 administration during ex vivo expansion of human articular chondrocytes in a serum-free medium redirects the cell phenotype toward hypertrophy. J Cell Physiol 227: 3282-3290.
100. Nilsson O, Marino R, De Luca F, et al. 2005; Endocrine regulation of the growth plate. Horm Res 64: 157-165.
101. Noonan KJ, Hunziker EB, Nessler J, et al. 1998; Changes in cell, matrix compartment, and fibrillar collagen volumes between growth-plate zones. J Orthop Res 16: 500-508.
102. Oe K, Miwa M, Sakai Y, et al. 2007; An in vitro study demonstrating that haematomas found at the site of human fractures contain progenitor cells with multilineage capacity. J Bone Joint Surg Br 89: 133-138.
103. Oliveira SM, Amaral IF, Barbosa MA, et al. 2009a; Engineering endochondral bone: in vitro studies. Tissue Eng A 15: 625-634.
104. Oliveira SM, Mijares DQ, Turner G, et al. 2009b; Engineering endochondral bone: in vivo studies. Tissue Eng A 15: 635-643.
105. Oliveira SM, Ringshia RA, Legeros RZ, et al. 2010; An improved collagen scaffold for skeletal regeneration. J Biomed Mater Res A 94: 371-379.
106. Ortega N, Wang K, Ferrara N, et al. 2010; Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation. Dis Model Mech 3: 224-235.
107. Oshin AO, Caporali E, Byron CR, et al. 2007; Phenotypic maintenance of articular chondrocytes in vitro requires BMP activity. Vet Comp Orthop Traumatol 20: 185-191.
108. Palmer GD, Piton AH, Thant LM, et al. 2010; F-spondin regulates chondrocyte terminal differentiation and endochondral bone formation. J Orthop Res 28: 1323-1329.
109. Palmer GD, Steinert A, Pascher A, et al. 2005; Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Mol Ther 12: 219-228.
110. Pelttari K, Winter A, Steck E, et al. 2006; Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 54: 3254-3266.
111. Phelps EA, Garcia AJ. 2009; Update on therapeutic vascularization strategies. Regen Med 4: 65-80.
112. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
113. Prockop DJ, Oh JY. 2012; Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther 20: 14-20.
114. Puri MC, Nagy A. 2012; Concise review: embryonic stem cells versus induced pluripotent stem cells: the game is on. Stem Cells 30: 10-14.
115. Re'em T, Tsur-Gang O, Cohen S. 2010; The effect of immobilized RGD peptide in macroporous alginate scaffolds on TGFβ1-induced chondrogenesis of human mesenchymal stem cells. Biomaterials 31: 6746-6755.
116. Rivron NC, Raiss CC, Liu J, et al. 2012; Sonic Hedgehog-activated engineered blood vessels enhance bone tissue formation. Proc Natl Acad Sci U S A 109: 4413-4418.
117. Rosenthal AK, Henry LA. 1999; Thyroid hormones induce features of the hypertrophic phenotype and stimulate correlates of CPPD crystal formation in articular chondrocytes. J Rheumatol 26: 395-401.
118. Santo VE, Gomes ME, Mano JF, et al. 2013; Controlled release strategies for bone, cartilage, and osteochondral engineering-part I: recapitulation of native tissue healing and variables for the design of delivery systems. Tissue Eng B Rev 19: 308-326.
119. Sacchetti B, Funari A, Michienzi S, et al. 2007; Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336.
120. Schindler OS. 2011; Current concepts of articular cartilage repair. Acta Orthop Belg 77: 709-726.
121. Scotti C, Piccinini E, Takizawa H, et al. 2013; Engineering of a functional bone organ through endochondral ossification. Proc Natl Acad Sci U S A 110: 3997-4002.
122. Scotti C, Tonnarelli B, Papadimitropoulos A, et al. 2010; Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci U S A 107: 7251-7256.
123. Seda Tigli R, Ghosh S, Laha MM, et al. 2009; Comparative chondrogenesis of human cell sources in 3D scaffolds. J Tissue Eng Regen Med 3: 348-360.
124. Shapiro F. 2008; Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater 15: 53-76.
125. Sheehy EJ, Buckley CT, Kelly DJ. 2011; Chondrocytes and bone marrow-derived mesenchymal stem cells undergoing chondrogenesis in agarose hydrogels of solid and channelled architectures respond differentially to dynamic culture conditions. J Tissue Eng Regen Med 5: 747-758.
126. Sheehy EJ, Vinardell T, Buckley CT, et al. 2013; Engineering osteochondral constructs through spatial regulation of endochondral ossification. Acta Biomater 9: 5484-5492.
127. Sheehy EJ, Vinardell T, Toner ME, Buckley CT, Kelly DJ. 2014; Altering the architecture of tissue engineered hypertrophic cartilaginous grafts facilitates vascularisation and accelerates mineralisation. PLoS One 9: e90716.
128. Shegarfi H, Reikeras O. 2009; Review article: bone transplantation and immune response. J Orthop Surg (Hong Kong) 17: 206-211.
129. Sheridan WS, Duffy GP, Murphy BP. 2012; Mechanical characterization of a customized decellularized scaffold for vascular tissue engineering. J Mech Behav Biomed Mater 8: 58-70.
130. Shoji T, Ii M, Mifune Y, et al. 2010; Local transplantation of human multipotent adipose-derived stem cells accelerates fracture healing via enhanced osteogenesis and angiogenesis. Lab Invest 90: 637-649.
131. Smith EL, Kanczler JM, Oreffo RO. 2013; A new take on an old story: chick limb organ culture for skeletal niche development and regenerative medicine evaluation. Eur Cell Mater 26: 91-106.
132. Steinert AF, Proffen B, Kunz M, et al. 2009; Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther 11: R148.
133. Steinert AF, Weissenberger M, Kunz M, et al. 2012; Indian hedgehog gene transfer is a chondrogenic inducer of human mesenchymal stem cells. Arthritis Res Ther 14: R168.
134. Steward AJ, Wagner DR, Kelly DJ. 2013; The pericellular environment regulates cytoskeletal development and the differentiation of mesenchymal stem cells and determines their response to hydrostatic pressure. Eur Cell Mater 25: 167-178.
135. Sukmana I. 2012; Bioactive polymer scaffold for fabrication of vascularized engineering tissue. J Artif Organs 15: 215-224.
136. Tasso R, Fais F, Reverberi D, et al. 2010; The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model. Biomaterials 31: 2121-2129.
137. Tasso R, Ulivi V, Reverberi D, et al. 2013; In vivo implanted bone marrow-derived mesenchymal stem cells trigger a cascade of cellular events leading to the formation of an ectopic bone regenerative niche. Stem Cells Dev 22: 3178-3191.
138. Teixeira CC, Nemelivsky Y, Karkia C, et al. 2006; Biphasic calcium phosphate: a scaffold for growth plate chondrocyte maturation. Tissue Eng 12: 2283-2289.
139. Thorpe SD, Buckley CT, Steward AJ, et al. 2012; European Society of Biomechanics S. M. Perren Award 2012: the external mechanical environment can override the influence of local substrate in determining stem cell fate. J Biomech 45: 2483-2492.
140. Tian L, George SC. 2011; Biomaterials to prevascularize engineered tissues. J Cardiovasc Transl Res 4: 685-698.
141. Tierney CM, Haugh MG, Liedl J, et al. 2009; The effects of collagen concentration and crosslink density on the biological, structural and mechanical properties of collagen-GAG scaffolds for bone tissue engineering. J Mech Behav Biomed Mater 2: 202-209.
142. Toh WS, Lim TC, Kurisawa M, et al. 2012; Modulation of mesenchymal stem cell chondrogenesis in a tunable hyaluronic acid hydrogel microenvironment. Biomaterials 33: 3835-3845.
143. Tortelli F, Tasso R, Loiacono F, et al. 2010; The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials 31: 242-249.
144. Tremblay PL, Hudon V, Berthod F, et al. 2005; Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am J Transpl 5: 1002-1010.
145. Tsigkou O, Pomerantseva I, Spencer JA, et al. 2010; Engineered vascularized bone grafts. Proc Natl Acad Sci U S A 107: 3311-3316.
146. Vacanti CA, Kim W, Upton J, et al. 1995; The efficacy of periosteal cells compared to chondrocytes in the tissue engineered repair of bone defects. Tissue Eng 1: 301-308.
147. Vinardell T, Sheehy EJ, Buckley CT, et al. 2012; A comparison of the functionality and in vivo phenotypic stability of cartilaginous tissues engineered from different stem cell sources. Tissue Eng A 18: 1161-1170.
148. Wang L, Shao YY, Ballock RT. 2011; Leptin synergizes with thyroid hormone signaling in promoting growth plate chondrocyte proliferation and terminal differentiation in vitro. Bone 48: 1022-1027.
149. Wang L, Shao YY, Ballock RT. 2012; Leptin antagonizes peroxisome proliferator-activated receptor-γ signaling in growth plate chondrocytes. PPAR Res 2012: 756198.
150. Wang X, Wenk E, Zhang X, et al. 2009; Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release 134: 81-90.
151. Weiss HE, Roberts SJ, Schrooten J, et al. 2012; A semi-autonomous model of endochondral ossification for developmental tissue engineering. Tissue Eng A 18: 1334-1343.
152. Williams JA, Kane M, Okabe T, et al. 2010; Endogenous retinoids in mammalian growth plate cartilage: analysis and roles in matrix homeostasis and turnover. J Biol Chem 285: 36674-36681.
153. Wise JK, Alford AI, Goldstein SA, et al. 2014; Comparison of uncultured marrow mononuclear cells and culture-expanded mesenchymal stem cells in 3D collagen-chitosan microbeads for orthopedic tissue engineering. Tissue Eng A 20: 210-224.
154. Yakar S, Rosen CJ, Beamer WG, et al. 2002; Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110: 771-781.
155. Yang W, Yang F, Wang Y, et al. 2013; In vivo bone generation via the endochondral pathway on three-dimensional electrospun fibers. Acta Biomater 9: 4505-4512.
156. Yannas IV, Lee E, Orgill DP, et al. 1989; Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin, Proc Natl Acad Sci U S A 86: 933-937.
157. Yoshimura H, Muneta T, Nimura A, et al. 2007; Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 327: 449-462.
158. Yu YY, Lieu S, Lu C, et al. 2010; Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone 47: 65-73.
159. Zhou XZ, Leung VY, Dong QR, et al. 2008; Mesenchymal stem cell-based repair of articular cartilage with polyglycolic acid-hydroxyapatite biphasic scaffold. Int J Artif Organs 31: 480-489.
160. Zhou Y, Guan X, Wang H, et al. 2013; Hypoxia induces osteogenic/angiogenic responses of bone marrow-derived mesenchymal stromal cells seeded on bone-derived scaffolds via ERK1/2 and p38 pathways. Biotechnol Bioeng 110: 1794-1804.